Matches in SemOpenAlex for { <https://semopenalex.org/work/W2568740110> ?p ?o ?g. }
- W2568740110 endingPage "11371" @default.
- W2568740110 startingPage "11356" @default.
- W2568740110 abstract "Our previous research indicated miR-410 played a critical role in promoting the tumorigenesis and development of NSCLC (non-small cells lung cancer). MiR-410 has been recently reported to be crucial for development and differentiation of embryonic stem cells. But it remains elusive whether miR-410 stimulates the stemness of cancer until now. Herein, we identify miR-410 induces the stemness and is associated with the progression of NSCLC. We demonstrate miR-410 increases the levels of stem cells marker Sox2, Oct4, Nanog, CXCR4 as well as lung cancer stem cells surface marker CD44 and CD166. MiR-410 promotes stem cells-like properties such as proliferation, sphere formation, metastasis and chemoresistance. Moreover, Gsk3β is directly targeted and post-transcriptionally downregulated by miR-410. Also, the expression levels of miR-410 and Gsk3β may be correlated to clinicopathological differentiation in NSCLC tumor specimens. Additionally, we demonstrate miR-410 induces stemness through inhibiting Gsk3β but increasing Sox2, Oct4, Nanog and CXCR4, which binds to β-catenin signaling. In conclusion, our findings identify the miR-410/Gsk3β/β-catenin signaling axis is a novel molecular circuit in inducing stemness of NSCLC." @default.
- W2568740110 created "2017-01-13" @default.
- W2568740110 creator A5004361542 @default.
- W2568740110 creator A5006434354 @default.
- W2568740110 creator A5009921747 @default.
- W2568740110 creator A5020937100 @default.
- W2568740110 creator A5025030643 @default.
- W2568740110 creator A5034440003 @default.
- W2568740110 creator A5034574451 @default.
- W2568740110 creator A5050661386 @default.
- W2568740110 creator A5059361862 @default.
- W2568740110 creator A5075986593 @default.
- W2568740110 creator A5080431093 @default.
- W2568740110 creator A5085615634 @default.
- W2568740110 creator A5090870832 @default.
- W2568740110 date "2017-01-05" @default.
- W2568740110 modified "2023-10-17" @default.
- W2568740110 title "MiR-410 induces stemness by inhibiting Gsk3β but upregulating β-catenin in non-small cells lung cancer" @default.
- W2568740110 cites W1256634537 @default.
- W2568740110 cites W1510931988 @default.
- W2568740110 cites W1581943791 @default.
- W2568740110 cites W1591533704 @default.
- W2568740110 cites W1594221952 @default.
- W2568740110 cites W1634080553 @default.
- W2568740110 cites W1894832831 @default.
- W2568740110 cites W1911599821 @default.
- W2568740110 cites W1966461436 @default.
- W2568740110 cites W1969985049 @default.
- W2568740110 cites W1971714772 @default.
- W2568740110 cites W1980387419 @default.
- W2568740110 cites W1994928797 @default.
- W2568740110 cites W1995447552 @default.
- W2568740110 cites W1998517807 @default.
- W2568740110 cites W1999503941 @default.
- W2568740110 cites W2002428403 @default.
- W2568740110 cites W2003757313 @default.
- W2568740110 cites W2012087132 @default.
- W2568740110 cites W2013614359 @default.
- W2568740110 cites W2026845929 @default.
- W2568740110 cites W2030925636 @default.
- W2568740110 cites W2044197828 @default.
- W2568740110 cites W2045812012 @default.
- W2568740110 cites W2047122761 @default.
- W2568740110 cites W2049410632 @default.
- W2568740110 cites W2051935450 @default.
- W2568740110 cites W2056360747 @default.
- W2568740110 cites W2066565546 @default.
- W2568740110 cites W2073759231 @default.
- W2568740110 cites W2088301374 @default.
- W2568740110 cites W2111629903 @default.
- W2568740110 cites W2120768573 @default.
- W2568740110 cites W2126524543 @default.
- W2568740110 cites W2131170195 @default.
- W2568740110 cites W2131261050 @default.
- W2568740110 cites W2143995836 @default.
- W2568740110 cites W2150163104 @default.
- W2568740110 cites W2157750769 @default.
- W2568740110 cites W2158992273 @default.
- W2568740110 cites W2167414381 @default.
- W2568740110 cites W2168854899 @default.
- W2568740110 cites W2170552969 @default.
- W2568740110 cites W2191123825 @default.
- W2568740110 cites W2291973364 @default.
- W2568740110 cites W2736520162 @default.
- W2568740110 doi "https://doi.org/10.18632/oncotarget.14529" @default.
- W2568740110 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5355270" @default.
- W2568740110 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28076327" @default.
- W2568740110 hasPublicationYear "2017" @default.
- W2568740110 type Work @default.
- W2568740110 sameAs 2568740110 @default.
- W2568740110 citedByCount "37" @default.
- W2568740110 countsByYear W25687401102017 @default.
- W2568740110 countsByYear W25687401102018 @default.
- W2568740110 countsByYear W25687401102019 @default.
- W2568740110 countsByYear W25687401102020 @default.
- W2568740110 countsByYear W25687401102021 @default.
- W2568740110 countsByYear W25687401102022 @default.
- W2568740110 countsByYear W25687401102023 @default.
- W2568740110 crossrefType "journal-article" @default.
- W2568740110 hasAuthorship W2568740110A5004361542 @default.
- W2568740110 hasAuthorship W2568740110A5006434354 @default.
- W2568740110 hasAuthorship W2568740110A5009921747 @default.
- W2568740110 hasAuthorship W2568740110A5020937100 @default.
- W2568740110 hasAuthorship W2568740110A5025030643 @default.
- W2568740110 hasAuthorship W2568740110A5034440003 @default.
- W2568740110 hasAuthorship W2568740110A5034574451 @default.
- W2568740110 hasAuthorship W2568740110A5050661386 @default.
- W2568740110 hasAuthorship W2568740110A5059361862 @default.
- W2568740110 hasAuthorship W2568740110A5075986593 @default.
- W2568740110 hasAuthorship W2568740110A5080431093 @default.
- W2568740110 hasAuthorship W2568740110A5085615634 @default.
- W2568740110 hasAuthorship W2568740110A5090870832 @default.
- W2568740110 hasBestOaLocation W25687401101 @default.
- W2568740110 hasConcept C104317684 @default.
- W2568740110 hasConcept C107459253 @default.
- W2568740110 hasConcept C121608353 @default.
- W2568740110 hasConcept C126322002 @default.
- W2568740110 hasConcept C129470790 @default.